Valeo Financial Advisors, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1722641
CARMEL, IN
Position in VRTX
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$1,881,116
+$318,226 QoQ
Shares Held
3,787
+8.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#685
of 1,726 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$442,970
PutShares
1,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $6,495,341 across 14 Biotechnology names. VRTX ranks #1 (29.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,787 | $1,881,116 | |
| 2 | ARGX |
Argenx SE
|
1,077 | $999,208 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,289 | $803,743 | |
| 4 | RLAY |
Relay Therapeutics, Inc.
|
35,687 | $667,703 | |
| 5 | MRNA |
Moderna, Inc.
|
7,412 | $519,062 | |
| 6 | VCEL |
Vericel Corp
|
9,289 | $413,267 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
6,033 | $331,453 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,838 | $241,563 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,881,116 | 3,787 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $1,562,890 | 3,500 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,122,631 | 4,682 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,862,639 | 4,756 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $2,035,009 | 4,571 | Shares | Sole | 2025-09-12 | |
| 2025-03-31 | $2,297,077 | 4,738 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $442,970 | 1,100 | Put | Sole | 2025-01-30 | |
| 2024-12-31 | $2,485,867 | 6,173 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,988,139 | 6,425 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $2,758,417 | 5,885 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $2,649,347 | 6,338 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,279,804 | 5,603 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $1,511,625 | 4,347 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $1,517,084 | 4,311 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,683,103 | 5,342 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $1,351,490 | 4,680 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,525,875 | 5,270 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $1,200,707 | 4,261 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $862,505 | 3,305 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $488,610 | 2,225 | Shares | Sole | 2022-01-07 | |
| 2021-03-31 | $1,116,783 | 5,197 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $1,182,172 | 5,002 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $112,113 | 412 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $238,925 | 823 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $163,709 | 688 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||